Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus
Status:
Recruiting
Trial end date:
2023-11-06
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to characterize the long-term safety and tolerability of
BMS-986165 in subjects with Systemic Lupus Erythematosus (SLE).